Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
About this study
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
- Condition
- Chronic Myeloid Leukemia, Chronic Phase Chronic Myelogenous Leukemia
- Tested
- Interview
- Sponsor
- University of California, Irvine
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Study condition: Chronic Myeloid Leukemia, Chronic Phase Chronic Myelogenous Leukemia
- 18 years of age or older
- Diagnosed with chronic myeloid leukemia (CML) and in the chronic phase (CML-CP)
- Currently being treated with one of four cancer medications - imatinib, dasatinib, bosutinib, or nilotinib
- A patient at the UCI Chao Family Comprehensive Cancer Center (CFCCC), or
- A member of a patient support group organized by the CML Buster Foundation
- Do not meet any of the criteria listed under "Exclusion Requirements"
Exclusion 2
- Unable to read and speak English
- Impaired decisional capacity to consent
Where
1 site, 1 recruiting
Chao Family Comprehensive Cancer Center University of California, Irvine
Orange, California, United States
Contact
-
Chao Family Comprehensive Cancer Center University of California, Irvine
1-877-827-8839 ucstudy@uci.edu
-
University of California Irvine Medical
Potential match only. Final eligibility is determined by the study team.